Home > Balance Sheet > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Total Non-Current Liabilities

    Back to Balance Sheet
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹111 Cr₹108 Cr₹125 Cr₹159 Cr₹179 Cr

What is the latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Total Non-Current Liabilities ratio of GLAXOSMITHKLINE PHARMACEUTICALS is ₹111 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹111 Cr
Mar2024₹108 Cr
Mar2023₹125 Cr
Mar2022₹159 Cr
Mar2021₹179 Cr

How is Total Non-Current Liabilities of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹111 Cr
2.80
Mar2024 ₹108 Cr
-14.10
Mar2023 ₹125 Cr
-21.01
Mar2022 ₹159 Cr
-11.16
Mar2021 ₹179 Cr -

Compare Total Non-Current Liabilities of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹41,103.2 Cr 2.9% -2.6% 16.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,828.0 Cr -1.8% -6.4% -10.7% Stock Analytics
DIVIS LABORATORIES ₹158,227.0 Cr -0.3% -5.5% 8.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,045.0 Cr -0.1% 4% 18.7% Stock Analytics
CIPLA ₹105,961.0 Cr 1% -12.3% -5.2% Stock Analytics
DR REDDYS LABORATORIES ₹98,682.5 Cr -4.6% -7% 1.8% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

2.9%

-2.6%

16.2%

SENSEX

-0.2%

-4.2%

8.4%


You may also like the below Video Courses